Target Price | $3.25 |
Price | $2.35 |
Potential |
38.30%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Oramed Pharmaceuticals Inc. price target 2025.
The average Oramed Pharmaceuticals Inc. target price is $3.25.
This is
38.30%
register free of charge
|
|
A rating was issued by 1 analysts: 0 Analysts recommend Oramed Pharmaceuticals Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Oramed Pharmaceuticals Inc. stock has an average upside potential 2025 of
38.30%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.14 | 0.31 |
114.89% | 121.43% | |
P/E | 7.58 |
1 Analysts have issued a Oramed Pharmaceuticals Inc. forecast for earnings per share. The average Oramed Pharmaceuticals Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
2023 | $0.14 | 114.89% |
---|---|---|
2024 |
$0.31
121.43%
Unlock
|
Current | 4.62 | 232.00% |
---|---|---|
2024 |
7.58
64.07%
Unlock
|
Oramed Pharmaceuticals Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.